Official Title
Longitudinal Serological Study on the Spread and Course of COVID-19 Infections
Brief Summary

The overall goal is to study the immune response to SARS-CoV-2 infection over the period of one year in the blood of a representative cohort of ETH students/employees.

Completed
COVID-19
Virus Disease
Eligibility Criteria

Inclusion Criteria:

- ETH employee or ETH student and their family members living in the same household at
the start of the study

- Between 18 and 64 years of age at the start of the study

- Signed informed consent

Exclusion Criteria:

- Age over 64 years at the start of the study

- In quarantine or self-confinement at the start of the study

- Active COVID-19 infection at the start of the study:

- Diagnosed with a laboratory test

- Suspected based on typical symptoms such as fever (>38°C), acute pulmonary
ex-acerbation or sudden loss of gustatory taste

- The following medical condition

- With continuous steroid therapy/ chemotherapy/immunsuppressive therapy

- In treatment for cancer

- With severe autoimmune disease

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 64 Years
Countries
Switzerland
Locations

ETH
Zürich, Switzerland

Goldhahn Jörg
NCT Number
MeSH Terms
COVID-19
Virus Diseases